Drug · DIN 02483971
CRESEMBA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since May 2, 2019; first marketed May 2, 2019.
- Drug Identification Number (DIN)
- 02483971
- Company (DIN owner)
- Avir Pharma IncBlainville, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Isavuconazole J02AC05
- Class
- Human
- Record last updated
- July 10, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ISAVUCONAZOLE (ISAVUCONAZONIUM SULFATE) | 100 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 19, 2018: NOC 21636New Drug Submission (NDS)
Other DINs named CRESEMBA
- DIN 02483998 · Marketed
- DIN 02553279 · Marketed